Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(
1
)
Home
|
Portfolio
|
Market Currents
|
Investing Ideas
|
Dividends & Income
|
ETFs
|
Macro View
|
ALERTS
|
PRO
This Market Current was sent to
2,360
people who get email alerts on SYK.
Get email alerts on SYK »
Market Currents
All
Top Stories
Breaking News
On the Move
Quick Ideas
Earnings
Dividends
M&A
U.S. Economy
Global & FX
Commodities
ETFs
Tech
Consumer
Energy
Financials
Healthcare
Stryker (SYK): Q4 EPS of $1.14 beats by $0.01. Revenue of $2.34B (+4.2% Y/Y) beats by $70M. (PR)
Wednesday, January 23, 4:07 PM ET
Stryker (
SYK
):
Q4 EPS of $1.14
beats by $0.01
. Revenue of $2.34B (+4.2% Y/Y)
beats by $70M
. (
PR
)
This Market Current was sent to
2,360
people who get email alerts on SYK.
Get email alerts on SYK »
Share this Market Current
Short URL:
Tweet
Load All Comments
LATEST
|
TODAY SO FAR
|
YESTERDAY
Other date
DJIA (
DIA
)
S&P 500 (
SPY
)
HEALTHCARE ETF
s
IN FOCUS
Latest Healthcare Articles
Diabetes And Oncology Might Cushion Eli Lilly's Fall Off A Patent Cliff
6:19 PM
•
Cory Renauer
Vical Has A Deep Bench And Near-Term Catalysts
4:13 PM
•
Gregory Stuckey
Exelixis Prepares For ASCO 2013, Stock Stays Rangebound
3:23 PM
•
Brian L. Wilson
Successful Capital Raise, Data For Lead Candidate, And Small Float Are Opportunitites For Stemline
1:21 PM
•
PropThink
All Amarin Eyes On Sunday's Prescription Data
1:20 PM
•
Quoth the Raven
Acadia: Multiple Data Points Suggest Further Upside In The Stock
11:00 AM
•
Josh Hutheson
Actavis Buys Warner Chilcott, Upside Seems Limited
10:51 AM
•
New Low Observer
2 Healthcare Companies With Recent Intensive Insider Buying
8:38 AM
•
Markus Aarnio
United Therapeutics: A Growth Stock With Good Products And A Promising Pipeline
8:28 AM
•
StockRiters
A Review Of Upcoming Catalysts For Kidney Disease Biotech Players In 2013
8:17 AM
•
Tech Guru
Amarin Stays Rangebound, Prescriptions Stagnate
6:17 AM
•
Brian L. Wilson
Vivus Heats Up, Shorts Discouraged On Possible Bidding War
5:41 AM
•
Brian L. Wilson
Dividend Growth Gem Medtronic Is A Cash Cow
4:39 AM
•
Valuentum
Amgen: Financial Analysis And Valuation
3:26 AM
•
Shankar N
Arena - Good Sales, Bad Sales, Long And Short
2:53 AM
•
Spencer Osborne
More Latest Articles »